Patients discontinue BTKi's due to resistance and intolerance. We evaluated the safety and efficacy...
Some very encouraging news for those with unmutated IGHV and/or TP53 aberrations, who are wondering...
Hi All,
If you haven’t seen it, here is a interesting study done at the James Center at Ohio State...
This is the first significant change to report, other than the reduction of lymph nodes after the...
On behalf of the Leukemia & Lymphoma Society, thank you again for joining the LLS National Patient...